Common Equity (Quarterly)

Common Equity: The sum of all common equity items.

Treace Medical Concepts, Inc. (TMCI) had Common Equity of $77.19M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$47.20M
Net Income	$-17.96M
Cost of Goods Sold	$9.79M
Gross Profit	$37.41M
Operating Expenses	$64.36M
Operating Income	$-17.17M
Non-Operating Income/Expense	$-0.79M
Pre-Tax Income	$-17.96M
Normalized Pre-Tax Income	$-17.96M
Income after Taxes	$-17.96M
Income from Continuous Operations	$-17.96M
Consolidated Net Income/Loss	$-17.96M
Normalized Income after Taxes	$-17.96M
EBIT	$-17.17M
EBITDA	$-16.00M
Weighted-Average Shares Outstanding (Basic)	64.59M
Weighted-Average Shares Outstanding (Diluted)	64.59M
Earnings per Share (EPS) (Basic)	$-0.28
Earnings per Share (EPS) (Diluted)	$-0.28
Balance Sheet Financials
Current Assets	$123.47M
Property, Plant, and Equipment	$32.06M
Long-Term Assets	$60.63M
Total Assets	$184.10M
Current Liabilities	$34.49M
Long-Term Debt	$55.82M
Long-Term Liabilities	$72.42M
Total Liabilities	$106.91M
Common Equity	$77.19M
Tangible Shareholders Equity	$57.49M
Shareholders Equity	$77.19M
Common Shares Outstanding	64.79M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$7.24M
Cash Flow from Investing Activities	$-7.82M
Cash Flow from Financial Activities	$-0.59M
Beginning Cash	$10.71M
End Cash	$9.54M
Increase/Decrease in Cash	$-1.16M
Stock-Based Compensation	$8.03M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.58
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.42
Debt to Equity Ratio	0.72
Gross Margin	79.26%
Operating Margin	-36.37%
EBIT Margin	-36.37%
EBITDA Margin	--
Pre-Tax Profit Margin	-38.05%
Profit Margin	-38.05%
Free Cash Flow	$4.18M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.26
Inventory Turnover	0.27
Receiveable Turnover	1.55
Days Sales in Receivables	57.89
Return on Equity	-23.27%
Return on Tangible Equity	-31.24%
Return on Assets	-9.76%
Return on Investments	-13.50%
Book Value Per Share	$1.19
Free Cash Flow per Share	$0.06
Operating Cash Flow per Share	$0.11

Data from Zacks Investment Research, Inc.